132 related articles for article (PubMed ID: 20129645)
1. Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.
Pancione M; Forte N; Fucci A; Sabatino L; Febbraro A; Di Blasi A; Daniele B; Parente D; Colantuoni V
Hum Pathol; 2010 Jun; 41(6):867-76. PubMed ID: 20129645
[TBL] [Abstract][Full Text] [Related]
2. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial genomic instability in colorectal cancer: no correlation to nuclear microsatellite instability and allelic deletion of hMSH2, hMLH1, and p53 genes, but prediction of better survival for Dukes' stage C disease.
Tsai MH; Fang WH; Lin SW; Yen SJ; Chou SJ; Yang YC
Ann Surg Oncol; 2009 Oct; 16(10):2918-25. PubMed ID: 19582509
[TBL] [Abstract][Full Text] [Related]
4. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
[TBL] [Abstract][Full Text] [Related]
5. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
[TBL] [Abstract][Full Text] [Related]
7. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.
Gafà R; Maestri I; Matteuzzi M; Santini A; Ferretti S; Cavazzini L; Lanza G
Cancer; 2000 Nov; 89(10):2025-37. PubMed ID: 11066042
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin and p53 expression in topographic compartments of colorectal cancer and its prognostic value following surgery.
Prieto JD; Álvarez M; Hierro MI; García I; Vicioso L
Ann Diagn Pathol; 2017 Dec; 31():1-8. PubMed ID: 29146051
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic biomarkers for metastatic colorectal cancer].
Neumann JH
Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and analysis of microsatellite instability in resected pulmonary metastases from colorectal carcinoma.
Melloni G; Doglioni C; Bandiera A; Carretta A; Ciriaco P; Arrigoni G; Zannini P
Ann Thorac Surg; 2006 Jun; 81(6):2008-13. PubMed ID: 16731121
[TBL] [Abstract][Full Text] [Related]
11. A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer.
Neumann J; Horst D; Kriegl L; Maatz S; Engel J; Jung A; Kirchner T
Histopathology; 2012 Feb; 60(3):416-26. PubMed ID: 22276605
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic marker profiles for risk of distant metastases in colorectal cancer].
Neumann J; Reu S; Kirchner T
Pathologe; 2012 Feb; 33(1):39-44. PubMed ID: 22293788
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer.
Mårtensson A; Oberg A; Jung A; Cederquist K; Stenling R; Palmqvist R
Oncol Rep; 2007 Feb; 17(2):447-52. PubMed ID: 17203186
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma.
Senol S; Yildirim A; Ceyran B; Uruc F; Zemheri E; Ozkanli S; Akalin I; Ulus I; Caskurlu T; Aydin A
Bosn J Basic Med Sci; 2015 Aug; 15(4):7-14. PubMed ID: 26614845
[TBL] [Abstract][Full Text] [Related]
15. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
[TBL] [Abstract][Full Text] [Related]
16. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
Miyamoto S; Endoh Y; Hasebe T; Ishii G; Kodama K; Goya M; Ono M; Saitoh N; Chiba T; Ochiai A
Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of beta-catenin, p53 and proliferating cell nuclear antigen in the carcinogenesis of colorectal adenoma].
Wu W; Zhang X; Yan X; Wang J; Zhang J; Li Y
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):264-7. PubMed ID: 12515622
[TBL] [Abstract][Full Text] [Related]
19. Expression of sFRP-4 and beta-catenin in human colorectal carcinoma.
Feng Han Q; Zhao W; Bentel J; Shearwood AM; Zeps N; Joseph D; Iacopetta B; Dharmarajan A
Cancer Lett; 2006 Jan; 231(1):129-37. PubMed ID: 16356838
[TBL] [Abstract][Full Text] [Related]
20. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses.
Kim YH; Min BH; Kim SJ; Choi HK; Kim KM; Chun HK; Lee H; Kim JY; Chang DK; Son HJ; Rhee PL; Rhee JC; Kim JJ
Ann Surg Oncol; 2010 May; 17(5):1435-41. PubMed ID: 20049642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
